Ma. Eloisa J.

Yrogirog
Level III – N33
Drug Study Form

Name of Drug Classification Dose Mechanism of Indication Contraindication Adverse Effect Nursing Responsibility
Action
Tramadol Analgesics IVTT drip 25 Binds to mu- Moderate to Hypersensitivity; CNS: seizures, Assess BP and
(centrally acting) gtts/min. opioid receptors. moderately Cross-sensitivity dizziness, respiratory rate before
Inhibits reuptake severe pain with opioids may headache, and periodically during
of serotonin and (extended- occur; Patients somnolence, administration.
norepinephrine in release who are acutely anxiety, CNS Respiratory depression
the CNS. formulations intoxicated with stimulation, has not occurred with
indicated for alcohol, confusion, recommended doses.
Therapeutic patients who sedatives/hypnoti coordination
Effects: require around- cs, centrally acting disturbance, Assess bowel function
Decreased pain. the-clock pain analgesics, opioid euphoria, routinely. Prevention of
management). analgesics, or malaise, constipation should be
psychotropic nervousness, instituted with
agents; Patients sleep disorder, increased intake of
who are physically weakness. fluids and bulk and with
dependent on laxatives to minimize
opioid analgesics EENT: visual constipating effects
(may precipitate disturbances.
withdrawal). Monitor patient for
CV: seizures. May occur
Use Cautiously vasodilation. within recommended
in: dose range. Risk is
Patients with a GI: constipation, increased with higher
history of epilepsy nausea, doses and in patients
or risk factors for abdominal pain, taking antidepressants
seizures; Renal anorexia, (SSRIs, SNRIs, tricyclics,
 impairment; diarrhea, dry or MAO inhibitors),
Patients receiving mouth, opioid analgesics, or
MAO inhibitors, dyspepsia, other drugs that
neuroleptics, flatulence, decrease the seizure
SSRIs, or TCAs, or vomiting threshold.
other CNS
depressants; GU: urinary Lab Test
Patients who are retention/freque Considerations:
suicidal or prone ncy May cause increased
to addiction; ; Derm: pruritus, serum creatinine,
Excessive use of sweating. increased liver enzymes,
alcohol; and decreased hemoglobin,
Patients with a Neuro: and proteinuria.
history of opioid hypertonia.
dependence or Toxicity and Overdose:
who have recently Misc: Overdose may cause
received large SEROTONIN respiratory depression
doses of opioids. SYNDROME, and seizures. Naloxone
physical may reverse some, but
dependence, not all, of the symptoms
psychological of overdose. Treatment
dependence, should be symptomatic
tolerance. and supportive.
Maintain adequate
respiratory exchange.
Hemodialysis is not
helpful because it
removes only a small
portion of administered
dose. Seizures may be
managed with
barbiturates or
benzodiazepines;
naloxone increases risk
of seizures.

Advise patient to
change positions slowly
to minimize orthostatic
hypotension

Encourage patient to
turn, cough, and
breathe deeply every 2
hr to prevent
atelectasis.

Caution patient to avoid